next generation glp-1 What is the pipeline for future medications for obesity? Obesity plus': What's next for

BPC-157 TB-500 Side Effects & Safety BPC-157 Generally very well tolerated in research models Minimal reported side effects at standard doses No significant hormonal impact Theoretical concern: may promote angiogenesis in existing tumors (same as any pro-angiogenic compound) TB-500 Well tolerated

Further evidence for this hypothesis comes from recent yeast two-hybrid studies performed with enzymes from sweet peony, where the arGST Ps GSTF3 was found to interact with Ps DFR, the dihydroflavonol reductase catalysing the formation of 3,4- cis -leucocyanidin ( 6 ) 47

However, a central hypothesis presented in this study is that the AT4 receptor system coincides with the HGF/c-Met receptor system

It's easy to supplement, but are there any side effects

15 The study found that GLP-1 medication was associated with an 18% relative reduction in risk of developing any AMD from no AMD at baseline: 0.46% of the GLP-1 group had any AMD after 10 years, while 0.55% had any AMD in the control group

& Gulati, G